Catpharma produces the full range of finished products of biosimilar anabolic, peptides, sarms and orals hormones for therapeutic use under Good Manufacturing Practice (GMP)

The products are produced by our special raw material specifications; most of them are following US pharmacopeias (USP), Europe pharmacopeias (Ph. Eur.), British pharmacopeias (BP), The Pharmacopoeias of Japan (Jpn P.) or Pharmacopoeias in Poland ( Pol.P.) standard. All of them are passed through our independent quality control process.

According to the new International and local FDA regulations, the product license is mandatory to be displayed. Hence the standard concentrated control as mentioned is always applied in our production process with all our products. We constantly provide research and development for our products aiming to achieve our customer satisfaction as well as our significant brand value as leaders in endocrinology globally.